Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Peptides and small molecules that bind to peptide receptors are important classes of drugs that are used for a wide variety of different applications. The search for novel neuropeptides traditionally involved a time-consuming approach to purify each peptide to homogeneity and determine its amino acid sequence. The discovery in the 1980s of enkephalin convertase/carboxypeptidase E (CPE), and the observation that this enzyme was involved in the production of nearly every known neuropeptide led to the idea for a one-step affinity purification of CPE substrates. This approach was successfully used to isolate hundreds of known neuropeptides in mouse brain, as well as over a dozen novel peptides. Some of the novel peptides found using this approach are among the most abundant peptides present in brain, but had not been previously identified by traditional approaches. Recently, receptors for two of the novel peptides have been identified, confirming their role as neuropeptides that function in cell-cell signaling. Small molecules that bind to one of these receptors have been developed and found to significantly reduce food intake and anxiety-like behavior in an animal model. This review describes the entire project, from discovery of CPE to the novel peptides and their receptors.

Original languageEnglish (US)
JournalAdvances in Pharmacology
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Carboxypeptidase H
Neuropeptides
Peptides
Peptide Receptors
Therapeutics
Brain
Amino Acid Sequence
Anxiety
Animal Models
Eating
Enzymes

Keywords

  • Carboxypeptidase
  • Enkephalin
  • Neuropeptide
  • Peptidomics
  • ProSAAS

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{ddafb4e400f646a0a2700cc38d1fd6b1,
title = "Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets",
abstract = "Peptides and small molecules that bind to peptide receptors are important classes of drugs that are used for a wide variety of different applications. The search for novel neuropeptides traditionally involved a time-consuming approach to purify each peptide to homogeneity and determine its amino acid sequence. The discovery in the 1980s of enkephalin convertase/carboxypeptidase E (CPE), and the observation that this enzyme was involved in the production of nearly every known neuropeptide led to the idea for a one-step affinity purification of CPE substrates. This approach was successfully used to isolate hundreds of known neuropeptides in mouse brain, as well as over a dozen novel peptides. Some of the novel peptides found using this approach are among the most abundant peptides present in brain, but had not been previously identified by traditional approaches. Recently, receptors for two of the novel peptides have been identified, confirming their role as neuropeptides that function in cell-cell signaling. Small molecules that bind to one of these receptors have been developed and found to significantly reduce food intake and anxiety-like behavior in an animal model. This review describes the entire project, from discovery of CPE to the novel peptides and their receptors.",
keywords = "Carboxypeptidase, Enkephalin, Neuropeptide, Peptidomics, ProSAAS",
author = "Fricker, {Lloyd D.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/bs.apha.2017.09.001",
language = "English (US)",
journal = "Advances in Pharmacology",
issn = "1054-3589",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets

AU - Fricker, Lloyd D.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Peptides and small molecules that bind to peptide receptors are important classes of drugs that are used for a wide variety of different applications. The search for novel neuropeptides traditionally involved a time-consuming approach to purify each peptide to homogeneity and determine its amino acid sequence. The discovery in the 1980s of enkephalin convertase/carboxypeptidase E (CPE), and the observation that this enzyme was involved in the production of nearly every known neuropeptide led to the idea for a one-step affinity purification of CPE substrates. This approach was successfully used to isolate hundreds of known neuropeptides in mouse brain, as well as over a dozen novel peptides. Some of the novel peptides found using this approach are among the most abundant peptides present in brain, but had not been previously identified by traditional approaches. Recently, receptors for two of the novel peptides have been identified, confirming their role as neuropeptides that function in cell-cell signaling. Small molecules that bind to one of these receptors have been developed and found to significantly reduce food intake and anxiety-like behavior in an animal model. This review describes the entire project, from discovery of CPE to the novel peptides and their receptors.

AB - Peptides and small molecules that bind to peptide receptors are important classes of drugs that are used for a wide variety of different applications. The search for novel neuropeptides traditionally involved a time-consuming approach to purify each peptide to homogeneity and determine its amino acid sequence. The discovery in the 1980s of enkephalin convertase/carboxypeptidase E (CPE), and the observation that this enzyme was involved in the production of nearly every known neuropeptide led to the idea for a one-step affinity purification of CPE substrates. This approach was successfully used to isolate hundreds of known neuropeptides in mouse brain, as well as over a dozen novel peptides. Some of the novel peptides found using this approach are among the most abundant peptides present in brain, but had not been previously identified by traditional approaches. Recently, receptors for two of the novel peptides have been identified, confirming their role as neuropeptides that function in cell-cell signaling. Small molecules that bind to one of these receptors have been developed and found to significantly reduce food intake and anxiety-like behavior in an animal model. This review describes the entire project, from discovery of CPE to the novel peptides and their receptors.

KW - Carboxypeptidase

KW - Enkephalin

KW - Neuropeptide

KW - Peptidomics

KW - ProSAAS

UR - http://www.scopus.com/inward/record.url?scp=85034430386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034430386&partnerID=8YFLogxK

U2 - 10.1016/bs.apha.2017.09.001

DO - 10.1016/bs.apha.2017.09.001

M3 - Article

C2 - 29413529

AN - SCOPUS:85034430386

JO - Advances in Pharmacology

JF - Advances in Pharmacology

SN - 1054-3589

ER -